| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.400 | None | 1.000 | 49 | 0 | 1997 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.500 | None | 0.983 | 41 | 0 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.989 | 35 | 0 | 1991 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 0.978 | 26 | 0 | 2002 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 25 | 0 | 1990 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 22 | 0 | 1999 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.700 | None | 0.985 | 21 | 0 | 1997 | 2019 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.400 | None | 1.000 | 20 | 0 | 1996 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.957 | 19 | 0 | 2002 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.600 | None | 1.000 | 18 | 0 | 1998 | 2015 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.200 | None | 1.000 | 16 | 0 | 2003 | 2016 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2002 | 2013 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.500 | None | 0.950 | 15 | 0 | 1999 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 0.976 | 15 | 0 | 2003 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.300 | None | 1.000 | 14 | 0 | 2002 | 2013 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.400 | None | 1.000 | 13 | 0 | 2002 | 2014 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1996 | 2008 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1999 | 2013 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1996 | 2008 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 9 | 0 | 1999 | 2014 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
group | 0.100 | None | 1.000 | 8 | 0 | 1997 | 2015 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.200 | None | 1.000 | 8 | 0 | 2002 | 2016 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
group | 0.600 | None | 0.952 | 8 | 0 | 1999 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 8 | 0 | 1996 | 2008 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
group | 0.380 | None | 1.000 | 8 | 0 | 2002 | 2013 |